Recipharm Secures Financing for Future Growth
News May 23, 2012
Recipharm has announced that it has arranged a five-year loan facility with Swedbank AB (publ), one of the largest banks in Sweden.
The total loan facility of Euro 90 million will serve as an additional resource to facilitate future expansion plans set in place for the business, especially in the field of contract pharmaceutical development.
The funds will in part be targeted at increasing capital investment into Recipharm’s existing sites and facilities to meet expanding customer demand.
The finance will also be used to bolster the next phase of the company’s rolled out programme of strategic acquisitions.
Moroever, significant resources from the loan pool will be assigned to building and enhancing existing and new customer relationships.
Thomas Eldered, CEO of Recipham AB, commented: “The new financing will serve to bolster initiatives designed to build and foster strong customer relationships with all our clients across the pharmaceuticals sector. Indeed, Recipharm adopts a partnering approach to client relations to ensure that we consistently provide bespoke services that meet the precise needs of each individual customer both now and in the future. As a forward looking enterprise, we very much want to be there for the long term whilst at the same time having the flexible and established capabilities to respond rapidly to varying and immediate customer needs. Our programme of strategic acquisitions and investment in current facilities has always been geared towards increasing and expanding the services that we tailor to each specific client. We look forward to continuing in this vein.”
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE